Mangione Expected to Plead Guilty in Federal Case
Luigi Mangione is expected to plead guilty Friday to federal charges in connection with the December 2024 killing of UnitedHealthcare CEO Brian Thompson in Manhattan, according to sources familiar with the matter. The expected plea change comes less than a month before Mangione, 28, is scheduled to go to trial in a separate state murder case over the same alleged crime, as NBC News reported.
The Federal Charges
Mangione faces two federal counts of stalking resulting in death, each carrying a maximum sentence of life imprisonment. The Justice Department initially sought the death penalty in the federal case, but U.S. District Judge Margaret Garnett dismissed the death-eligible murder and firearms charges in January 2026, ruling they were legally incompatible with the stalking counts.
It remains unclear whether Mangione will plead guilty to one or both of the stalking-related charges. Sources stressed that plea negotiations are ongoing and nothing is final until Mangione himself accepts or enters into a plea deal — he could reverse his decision at any time, even during the hearing, according to NPR.
Mangione was meeting with his lawyers Thursday morning at the Metropolitan Detention Center in Brooklyn in advance of the federal court hearing, which was jointly requested by prosecutors and defense at 11 a.m. Friday in Manhattan federal court. U.S. Attorney for the Southern District of New York James McDonald declined to comment on the purpose of the session at a press conference Wednesday, saying only, “There’s a conference scheduled for 11 a.m. on Friday, that’s all we can say at this time.”
The State Case and Double Jeopardy
The plea development carries significant implications for Mangione’s separate state prosecution. Jury selection in the state murder trial is scheduled to begin September 8 before Justice Gregory Carro in Manhattan, where Mangione has pleaded not guilty to eight felony charges, including second-degree murder and several counts related to criminal possession of a weapon.
If Mangione pleads guilty to the federal charges, his lawyers are expected to seek dismissal of some or all of the charges in his state case based on New York’s double jeopardy rules, which strictly limit prosecuting a defendant more than once for the same criminal act. However, the Manhattan District Attorney’s Office, which has claimed “primary jurisdiction” because it charged Mangione with murder first, may argue the state murder charge addresses a legally different harm from the federal stalking charges, as Forbes reported.
In a letter filed last month to state Judge Gregory Carro, Assistant Manhattan District Attorney Joel Seidemann warned of complications if a federal plea deal is reached before a jury can hear the case. “If a proposed federal guilty plea would operate to defeat a just outcome in the state prosecution, the people [the Manhattan DA’s office] could advise the federal district court of that consequence,” Seidemann wrote, adding that any guilty pleas “must account for the seriousness of defendant’s offenses, the loss of an innocent life, the impact of those crimes on the victim’s family.”
Background: The Killing and Manhunt
Thompson, 50, a father of two, was shot and killed on December 4, 2024, outside the New York Hilton Midtown hotel hours before UnitedHealthcare was set to host an investor conference. The words “delay,” “deny,” and “depose” were written on spent bullet casings found at the scene, echoing a phrase used to describe how insurers avoid paying claims.
Mangione was arrested five days later at a McDonald’s in Altoona, Pennsylvania, after a customer recognized him from surveillance images, ending a dayslong, multistate manhunt. Authorities confiscated a 3D-printed gun, a suppressor, and a notebook prosecutors say contained plans to kill Thompson and writings critical of the U.S. healthcare and insurance industries, according to Wikipedia.
Prior Plea Negotiations
The expected plea follows earlier discussions between Mangione’s attorneys and federal prosecutors. In June, NBC News reported that an agreement appeared close but ultimately fell aside. Mangione’s attorney Karen Friedman Agnifilo publicly criticized the reporting at the time, calling it “part of a troubling, deliberate pattern by prosecutors and law enforcement to prejudice Luigi, manipulate public opinion, and violate his constitutional right to a fair trial and impartial jury.”
Legal experts say the plea talks are common before most trials. Gary Galperin, a professor of law at Cardozo School of Law and former prosecutor in the New York County district attorney’s office, told NPR that the surprise hearing scheduling was telling: “Why would they be going to federal court tomorrow when they should be preparing for the state trial? It would be reasonable to speculate that they may be trying to enter a guilty plea.”
What’s Next
Friday’s hearing in Manhattan federal court will determine the immediate trajectory of the case. If Mangione enters a guilty plea, his legal team is expected to file motions seeking to dismiss the state charges, setting up a potentially complex legal battle over double jeopardy that could reshape the entire prosecution.
If the plea negotiations fall through, Mangione would still face trial in federal court in January 2027, in addition to the state trial scheduled to begin next month. The case has drawn intense public scrutiny, with Mangione attracting both condemnation and support amid broader debates about the U.S. healthcare system.
Thompson’s killing and the subsequent legal proceedings have sparked nationwide conversations about healthcare costs and insurance practices. Whatever happens Friday, the outcome will mark a significant turning point in one of the most closely watched criminal cases in recent American history.